Mangoceuticals clarifies GLP-1 programs: no direct contracts with Eli Lilly or Novo Nordisk

MANGOCEUTICALS, INC.

MangoRx Direct and PeachesRx Direct can prescribe branded GLP-1s (Zepbound, Wegovy) via third-party provider.
Company has no direct contractual relationship with Eli Lilly or Novo Nordisk; access is through an independent provider.
Programs launched Nov 13, 2025 at $99/month; medication cost and fulfillment separate.
Clarification follows earlier press release that may have implied direct partnerships.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.